Deep Isolation Nuclear, Inc. and Subsidiaries Quarterly Report (Form 10-Q)
Deep Isolation Nuclear, Inc. and Subsidiaries Quarterly Report (Form 10-Q)
Deep Isolation Nuclear, Inc. (the “Company”) filed its quarterly report for the period ended June 30, 2026, reporting a net loss of $12.1 million for the three months ended June 30, 2026, compared to a net loss of $9.4 million for the same period in 2025. As of June 30, 2026, the Company had a total of $43.4 million in cash and cash equivalents, and a total of $57.7 million in outstanding shares of common stock. The Company’s condensed consolidated balance sheet as of June 30, 2026, showed total assets of $54.1 million, total liabilities of $24.5 million, and total stockholders’ deficit of $20.4 million. The Company’s condensed consolidated statement of operations and comprehensive loss for the three and six months ended June 30, 2026, showed a net loss of $12.1 million and $23.4 million, respectively.
Overview
Global demand for reliable, clean energy is growing rapidly, driven by increased power demand, climate change, extreme weather events, and geopolitical factors. Nuclear energy is a critical contributor to the energy future, but the disposal of nuclear waste remains a major challenge.
Deep Isolation’s mission is to revolutionize nuclear waste disposal through innovative solutions for temporary storage, transportation, and permanent disposal via deep underground boreholes. The company’s patented technology allows nuclear waste to be stored much deeper underground than traditional mined repositories, increasing safety.
To date, Deep Isolation has focused on securing grants, contracts, and awards from governments and NGOs to support research and development. The company has also entered strategic appraisal and operational planning contracts, but has not yet signed any binding implementation agreements with customers.
Deep Isolation’s wholly owned subsidiary, Freestone, provides environmental and water resources consulting services, generating supplemental cash flow for the company.
Financial Performance
Deep Isolation’s financial results for the six months ended June 30, 2026 show a significant increase in operating expenses, driven by a ramp-up in research and development activities. Key financial highlights include:
Revenue:
- Revenue decreased by 12% to $2.8 million for the six-month period, compared to $3.2 million in the prior year period. This was primarily due to the completion of certain projects in 2025.
Operating Expenses:
- Total operating expenses increased by 215% to $10.3 million, compared to $3.3 million in the prior year period.
- Selling, general and administrative expenses increased by 74% to $5.6 million, due to higher accounting, audit, legal, and insurance costs, as well as the addition of 7 new employees.
- Research and development expenses increased by $4.7 million to $4.7 million, attributed to the ordering of long-lead items and front-end engineering work for the company’s non-radioactive, full-scale, at-depth demonstration project.
Net Loss:
- Net loss increased by 453% to $8.5 million, compared to $1.5 million in the prior year period, due to the increase in operating expenses.
Liquidity and Capital Resources:
- As of June 30, 2026, the company had $19.4 million in cash, which it believes will be sufficient to meet its operating and research and development needs for at least the next 12 months.
- The company expects to invest approximately $16.3 million over the next 12 months, including $6.4 million in research and development and $9.9 million in operating costs.
Strengths and Weaknesses
Strengths:
- Innovative technology solution for permanent nuclear waste disposal, with the potential to significantly improve safety and reduce costs compared to traditional methods.
- Experienced leadership team with deep expertise in nuclear solutions, engineering, government/community engagement, and global strategy.
- Complementary consulting business (Freestone) that generates supplemental cash flow.
- Significant government funding and strategic partnerships to support research and development efforts.
Weaknesses:
- Reliance on government grants, contracts, and awards to fund operations, with no binding implementation agreements with customers to date.
- Substantial operating losses and negative cash flows from operations, requiring ongoing external funding.
- Regulatory hurdles and the need for legislative changes in the U.S. to allow for the commercialization of deep borehole disposal, which are outside the company’s control.
- Unproven technology, with the need for a successful non-radioactive, full-scale, at-depth demonstration to spur commercial adoption.
Outlook and Future Plans
Deep Isolation’s near-term focus is on completing a non-radioactive, full-scale, at-depth demonstration of its deep borehole disposal (DBD) technologies, which it expects will take approximately two years and cost around $15.5 million. The company believes this demonstration will validate the safety and feasibility of its solution, fostering enhanced engagement and support from potential clients and current customers.
The company expects that the successful completion of the demonstration will lead to increased client engagement, additional strategic appraisal and operational planning contracts, and ultimately, implementation contracts for its DBD services. However, the company acknowledges that it may continue to experience operating losses in 2026 and 2027 as it seeks to implement its long-term strategic plan.
The adoption of Deep Isolation’s technologies in the United States will require Congressional action in the form of legislative changes, which the company cannot guarantee will occur or be favorable to its objectives and business plan. As a result, the company may not achieve the growth potential it expects or may grow more slowly than expected, and it is difficult to project the success of its business model and operations.
Conclusion
Deep Isolation is pursuing an innovative and potentially transformative solution to the global nuclear waste disposal problem. The company’s technology offers the promise of increased safety and reduced costs compared to traditional methods, but it faces significant regulatory and commercial hurdles that will require substantial time and investment to overcome.
The company’s near-term focus on a non-radioactive, full-scale, at-depth demonstration is a critical step in validating its technology and building customer confidence. However, the company’s reliance on government funding and the uncertainty around legislative changes necessary for commercialization present ongoing risks to its long-term success.
Investors and stakeholders will need to closely monitor the company’s progress in completing the demonstration project, securing additional customer contracts, and navigating the regulatory landscape. The company’s ability to execute on its strategic plan and achieve commercial adoption of its solutions will be key to determining its future growth and financial performance.